6. Catassi C, Mirakian R, Natalini G, et al. Unresponsive enteropathy associated with circulating enterocyte autoantibodies in a boy with common variable hypogammaglobulinemia and type I diabetes. J Pediatr Gastroenterol Nutr. 1988;7:608-613.
7.
7. Levy M. Autoimmune enteropathy, anti-tubular basement membrane antibodies, and glomerulonephritis [letter; comment].J Pediatr. 1992;120:659-659.
8.
8. Colletti RB, Guillot AP, Rosen S, et al. Autoimmune enteropathy and nephropathy with circulating anti-epithelial cell antibodies [see comments]. J Pediatr. 1991;118:858-864.
9.
9. Lachaux A, Bouvier R, Cozzani E, et al. Familial autoimmune enteropathy with circulating anti-bullous pemphigoid antibodies and chronic autoimmune hepatitis. J Pediatr. 1994;125:858-862.
10.
10. Mitton SG, Mirakion R, Larcher VF, et al. Enteropathy and renal involvement in an infant with evidence of widespread autoimmune disturbance. J Pediatr Gastroenterol Nutr. 1989;8:397-400.
11.
11. Koskimies O, Klemola T, Savilahti E. Clinical quiz. A 1.5 year-old boy with autoimmune enteropathy. Pediatr Nephrol. 1995;9:124-126.
12.
12. Martini A, Scotta MS, Notarangelo LD, et al. Membranous glomerulopathy and chronic small-intestinal enteropathy associated with autoantibodies directed against renal tubular basement membrane and the cytoplasm of intestinal epithelial cells. Acta Paediatr Scand. 1983;72:931-934.
13.
13. Ellis D, Fisher SE, Smith WI Jr,Jaffe R. Familial occurrence of renal and intestinal disease associated with tissue autoantibodies. Am J Dis Child. 1982; 136:323-326.
14.
14. Hill S, Milla PJ, Ciampolillo A, et al. LFA-1 and ICAM-1 molecule expression in jejunal mucosa from children with autoimmune enteropathy. Autoimmunity. 1992;13:233-241.
15.
15. Mirakian R, Hill S, Richardson A, et al. HLA product expression and lymphocyte subpopulations in jejunum biopsies of children with idiopathic protracted diarrhoea and enterocyte autoantibodies. J Autoimmun. 1988;1:263-277.
16.
16. Lachaux A, Kaiserlian D, Bella C, Bouvier R. Flow cytometry characterization of epithelial cells released in the watery stools of a patient with autoimmune enteropathy [letter]. Am J Gastroenterol. 1995;90:856-857.
17.
17. Sanderson IR, Phillips AD, Spencer J, Walker-SmithJA. Response to autoimmune enteropathy to cyclosporin A therapy. Gut. 1991;32:1421-1425.
18.
18. Walker-Smith JA, Unsworth DJ, Hutchins P, et al. Autoantibodies against gut epithelium in child with small-intestinal enteropathy [letter]. Lancet. 1982;1:566-567.
19.
19. Mirakian R, Richardson A, Milla PJ, et al. Protracted diarrhoea of infancy: evidence in support of an autoimmune variant. Br Med J (Clin Res Ed). 1986;293:1132-1136.
20.
20. Savage MO, Mirakian R, Wozniak ER, et al. Specific autoantibodies to gut epithelium in two infants with severe protracted diarrhoea. JPediatr Gastroenterol Nutr. 1985;4:187-195.
21.
21. Wallemacq PE, Reding R. FK506 (tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspects. Clin. Chem. 1993;39:2219-2228.
22.
22. Venkataramanan R, Swaminathan A, Prasad T, et al. Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet. 1995;29:404-430.
23.
23. Winkler M, Christians U. A risk-benefit assessment of tacrolimus in transplantation. Drug Saf: 1995;12:348-357.
24.
24. Anonymous. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. The U.S. Multicenter FK506 Liver Study Group [see comments]. N Engl J Med. 1994;331:1110-1115.
25.
25. Anonymous. Randomized trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group [see comments]. Lancet. 1994;344:423-428.
26.
26. Lindholm A. Factors influencing the pharmacokinetics of cyclosporine in man. Ther Drug Monit. 1991;13:465-477.
27.
27. Snyder DS. Interaction between cyclosporine and warfarin [letter]. Ann Intern Med. 1988;108:311-311.
